Gene · 51203
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DELVE: feature selection for preserving biological trajectories in single-cell data. | Nat Commun | 2024 | 38553455 | PubTator, text mining | PubMed |
| In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia. | Mol Diagn Ther | 2024 | 38538969 | PubTator, text mining | PubMed |
| Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment. | Med Oncol | 2024 | 38526604 | PubTator, text mining | PubMed |
| Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC. | Discov Oncol | 2024 | 38441732 | PubTator, text mining | PubMed |
| Targeted nonviral delivery of genome editors in vivo. | Proc Natl Acad Sci U S A | 2024 | 38437567 | PubTator, text mining | PubMed |
| Comprehensive analysis of the potential pathogenesis of COVID-19 infection and liver cancer. | World J Gastrointest Oncol | 2024 | 38425388 | PubTator, text mining | PubMed |
| CCNB1 may as a biomarker for the adipogenic differentiation of adipose-derived stem cells in the postoperative fat transplantation of breast cancer. | Gland Surg | 2024 | 38323233 | PubTator, text mining | PubMed |
| Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis. | Sci Rep | 2024 | 38307969 | PubTator, text mining | PubMed |
| Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression. | J Exp Clin Cancer Res | 2024 | 38291438 | PubTator, text mining | PubMed |
| Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications. | Onco Targets Ther | 2024 | 38283733 | PubTator, text mining | PubMed |
| LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing. | Nat Commun | 2024 | 38272900 | PubTator, text mining | PubMed |
| Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment. | Int J Nanomedicine | 2024 | 38260239 | PubTator, text mining | PubMed |
| Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines. | J Biomed Sci | 2024 | 38233833 | PubTator, text mining | PubMed |
| NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduces AMPK phosphorylation. | BMC Cancer | 2024 | 38229038 | PubTator, text mining | PubMed |
| Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach. | Bioact Mater | 2024 | 38223537 | PubTator, text mining | PubMed |
| PEGylated therapeutics in the clinic. | Bioeng Transl Med | 2024 | 38193121 | PubTator, text mining | PubMed |
| WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy. | Eur J Med Res | 2024 | 38173030 | PubTator, text mining | PubMed |
| Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape. | Theranostics | 2024 | 38169577 | PubTator, text mining | PubMed |
| An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants. | NPJ Vaccines | 2024 | 38167505 | PubTator, text mining | PubMed |
| Machine learning-driven identification of the gene-expression signature associated with a persistent multiple organ dysfunction trajectory in critical illness. | EBioMedicine | 2024 | 38142638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51203/papers?page=8